{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:05:28Z","timestamp":1778767528171,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mitochondrion"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.mito.2019.07.006","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T19:51:02Z","timestamp":1564170662000},"page":"111-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Apomorphine rescues reactive oxygen species-induced apoptosis of fibroblasts with mitochondrial disease"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6180-7030","authenticated-orcid":false,"given":"Akihiko","family":"Miyauchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kouga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko F.","family":"Jimbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Matsuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1320-1165","authenticated-orcid":false,"given":"Hitoshi","family":"Osaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mito.2019.07.006_bb0005","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1021\/ml200095w","article-title":"A strategy for suppressing redox stress within mitochondria","volume":"2","author":"Arce","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.mito.2019.07.006_bb0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jns.2016.11.080","article-title":"Apomorphine pump in advanced Parkinson\u2019s disease: effects on motor and nonmotor symptoms with brain metabolism correlations","volume":"372","author":"Auffret","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.mito.2019.07.006_bb0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/jnnp-2012-304426","article-title":"A guide to diagnosis and treatment of Leigh syndrome","volume":"85","author":"Baertling","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.mito.2019.07.006_bb0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/10641960600549827","article-title":"Protection by apomorphine in two independent models of acute inhibition of oxidative metabolism in rodents","volume":"28","author":"Castri","year":"2006","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.mito.2019.07.006_bb0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pedneo.2014.03.009","article-title":"Diagnostic approach in infants and children with mitochondrial diseases","volume":"56","author":"Chi","year":"2015","journal-title":"Pediatr. Neonatol."},{"key":"10.1016\/j.mito.2019.07.006_bb0030","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10545-014-9796-2","article-title":"Treatment options for lactic acidosis and metabolic crisis in children with mitochondrial disease","volume":"38","author":"Danhauser","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.mito.2019.07.006_bb0035","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.freeradbiomed.2011.08.005","article-title":"Assessing bioenergetic function in response to oxidative stress by metabolic profiling","volume":"51","author":"Dranka","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mito.2019.07.006_bb0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1042\/bse0470115","article-title":"Roles of mitochondria in human disease","volume":"47","author":"Duchen","year":"2010","journal-title":"Essays Biochem."},{"key":"10.1016\/j.mito.2019.07.006_bb0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ajhg.2008.07.004","article-title":"Pathogenic mitochondrial DNA mutations are common in the general population","volume":"83","author":"Elliott","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mito.2019.07.006_bb0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ymgme.2011.10.009","article-title":"Initial experience in the treatment of inherited mitochondrial disease with EPI-743","volume":"105","author":"Enns","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mito.2019.07.006_bb0055","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fnins.2018.00342","article-title":"Mitochondrial quality control in neurodegenerative diseases: focus on Parkinson\u2019s disease and Huntington\u2019s disease","volume":"12","author":"Franco-Iborra","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.mito.2019.07.006_bb0060","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ymgme.2015.12.004","article-title":"Leigh syndrome: resolving the clinical and genetic heterogeneity paves the way for treatment options","volume":"117","author":"Gerards","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mito.2019.07.006_bb0065","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/jnr.20974","article-title":"Apomorphine protects against 6-hydroxydopamine-induced neuronal cell death through activation of the Nrf2-ARE pathway","volume":"84","author":"Hara","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.mito.2019.07.006_bb0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40478-015-0227-x","article-title":"Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNA(Trp)","volume":"3","author":"Hatakeyama","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.mito.2019.07.006_bb0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease and monogenic parkinsonism","volume":"51","author":"Hauser","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mito.2019.07.006_bb0080","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.22319","article-title":"Apomorphine treatment in Alzheimer mice promoting amyloid-beta degradation","volume":"69","author":"Himeno","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mito.2019.07.006_bb0085","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1124\/jpet.103.057455","article-title":"Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the proerectile effect of apomorphine","volume":"308","author":"Hsieh","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mito.2019.07.006_bb0090","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.parkreldis.2016.12.003","article-title":"Apomorphine \u2013 pharmacological properties and clinical trials in Parkinson\u2019s disease","volume":"33","author":"Jenner","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.mito.2019.07.006_bb0095","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cmet.2014.07.011","article-title":"Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization","volume":"20","author":"Jin","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.mito.2019.07.006_bb0100","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.1244360","article-title":"mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome","volume":"342","author":"Johnson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.mito.2019.07.006_bb0105","first-page":"124","article-title":"Diagnosis and treatment of mitochondrial myopathy--update review","volume":"42","author":"Koga","year":"2010","journal-title":"No To Hattatsu"},{"key":"10.1016\/j.mito.2019.07.006_bb0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.braindev.2017.08.005","article-title":"Japanese Leigh syndrome case treated with EPI-743","volume":"40","author":"Kouga","year":"2018","journal-title":"Brain Dev."},{"key":"10.1016\/j.mito.2019.07.006_bb0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/mol.108.046847","article-title":"Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich\u2019s ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class","volume":"74","author":"Lim","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mito.2019.07.006_bb0120","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s40265-016-0574-3","article-title":"Idebenone: a review in Leber\u2019s hereditary optic neuropathy","volume":"76","author":"Lyseng-Williamson","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.mito.2019.07.006_bb0125","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.freeradbiomed.2007.10.031","article-title":"Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma","volume":"44","author":"Marengo","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mito.2019.07.006_bb0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ebiom.2017.05.016","article-title":"Mitochonic Acid 5 (MA-5) facilitates ATP synthase oligomerization and cell survival in various mitochondrial diseases","volume":"20","author":"Matsuhashi","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mito.2019.07.006_bb0135","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1124\/jpet.102.039867","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes","volume":"303","author":"Millan","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mito.2019.07.006_bb0140","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.braindev.2018.02.007","article-title":"Leigh syndrome with spinal cord involvement due to a hemizygous NDUFA1 mutation","volume":"40","author":"Miyauchi","year":"2018","journal-title":"Brain Dev."},{"key":"10.1016\/j.mito.2019.07.006_bb0145","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.cmet.2013.10.001","article-title":"mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation","volume":"18","author":"Morita","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.mito.2019.07.006_bb0150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ymgme.2015.08.006","article-title":"Mutational and functional analysis of glucose transporter I deficiency syndrome","volume":"116","author":"Nakamura","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mito.2019.07.006_bb0155","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1083\/jcb.201808118","article-title":"Pink1\/Parkin link inflammation, mitochondrial stress, and neurodegeneration","volume":"217","author":"Newman","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mito.2019.07.006_bb0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2164-5-20","article-title":"Universal reference RNA as a standard for microarray experiments","volume":"5","author":"Novoradovskaya","year":"2004","journal-title":"BMC Genomics"},{"key":"10.1016\/j.mito.2019.07.006_bb0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease: new mechanistic insights and therapeutic perspectives","volume":"18","author":"Park","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.mito.2019.07.006_bb0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/B978-0-12-416618-9.00007-8","article-title":"Extracellular flux analysis to monitor glycolytic rates and mitochondrial oxygen consumption","volume":"542","author":"Pelletier","year":"2014","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.mito.2019.07.006_bb0175","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yexmp.2006.09.008","article-title":"Mitochondrial dysfunction and molecular pathways of disease","volume":"83","author":"Pieczenik","year":"2007","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.mito.2019.07.006_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040005","article-title":"A novel flow cytometric HTS assay reveals functional modulators of ATP binding cassette transporter ABCB6","volume":"7","author":"Polireddy","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mito.2019.07.006_bb0185","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1128\/JVI.00164-09","article-title":"Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy","volume":"83","author":"Porotto","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.mito.2019.07.006_bb0190","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0140-6736(11)61305-6","article-title":"Mitochondrial diseases","volume":"379","author":"Schapira","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.mito.2019.07.006_bb0195","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"1","author":"Schapira","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.mito.2019.07.006_bb0200","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1016\/j.bmcl.2011.04.085","article-title":"\u03b1-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging","volume":"21","author":"Shrader","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.mito.2019.07.006_bb0205","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41586-018-0448-9","article-title":"Parkin and PINK1 mitigate STING-induced inflammation","volume":"561","author":"Sliter","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.mito.2019.07.006_bb0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.parkreldis.2007.07.016","article-title":"Apomorphine for the acute treatment of \u201coff\u201d episodes in Parkinson\u2019s disease","volume":"14","author":"Stacy","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.mito.2019.07.006_bb0215","doi-asserted-by":"crossref","first-page":"11218","DOI":"10.1073\/pnas.0801661105","article-title":"A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators","volume":"105","author":"Stoilov","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mito.2019.07.006_bb0220","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/826046","article-title":"Neurodegeneration, mitochondrial dysfunction, and oxidative stress","volume":"2013","author":"Streck","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.mito.2019.07.006_bb0225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1620\/tjem.236.225","article-title":"Mitochonic Acid 5 (MA-5), a derivative of the plant hormone Indole-3-acetic acid, improves survival of fibroblasts from patients with mitochondrial diseases","volume":"236","author":"Suzuki","year":"2015","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.mito.2019.07.006_bb0230","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nature11707","article-title":"Mitochondrial disorders as windows into an ancient organelle","volume":"491","author":"Vafai","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.mito.2019.07.006_bb0235","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/373937","article-title":"Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease","volume":"72","author":"van der Walt","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mito.2019.07.006_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171052","article-title":"Repositioning approved drugs for the treatment of problematic cancers using a screening approach","volume":"12","author":"Varbanov","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.mito.2019.07.006_bb0245","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ana.24506","article-title":"Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders","volume":"78","author":"Yatsuga","year":"2015","journal-title":"Ann. Neurol."}],"container-title":["Mitochondrion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724919300029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724919300029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:24:01Z","timestamp":1761589441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567724919300029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":49,"alternative-id":["S1567724919300029"],"URL":"https:\/\/doi.org\/10.1016\/j.mito.2019.07.006","relation":{},"ISSN":["1567-7249"],"issn-type":[{"value":"1567-7249","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apomorphine rescues reactive oxygen species-induced apoptosis of fibroblasts with mitochondrial disease","name":"articletitle","label":"Article Title"},{"value":"Mitochondrion","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mito.2019.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and Mitochondria Research Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}